Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes

European Journal of Neurology

Volumn 20, Issue 12, 2013, Pages 1510-1516

  Runia, T F ^a   Jafari, N ^a   Hintzen, R Q ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinically isolated syndrome; Diagnostic criteria; Diagnostic test assessment; MRI; Multiple sclerosis

Indexed keywords

ACCURACY; ADULT; ARTICLE; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

CLINICALLY ISOLATED SYNDROME; DIAGNOSTIC CRITERIA; DIAGNOSTIC TEST ASSESSMENT; MRI; MULTIPLE SCLEROSIS;

DEMYELINATING DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 84887405054     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12243     Document Type: Article

References (22)

1. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
2. Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC. Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol 2009; 5: 672-682.
3. Freedman MS. Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology 2011; 76: S26-S34.
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
5. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald criteria'. Ann Neurol 2005; 58: 840-846.
6. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
7. Chard DT, Dalton CM, Swanton J, et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2011; 82: 176-179.
8. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-568.
9. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997; 120 (Pt 11) : 2059-2069.
10. Rovira A, Swanton J, Tintore M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009; 66: 587-592.
11. Tintore M, Rovira A, Brieva L, et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001; 7: 359-363.
12. Diaz-Sanchez M, Mayra G-MS, Asuncion M-OM, et al. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes. Mult Scler 2010; 16: 576-580.
13. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 702-706.
14. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6: 677-686.
15. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47-53.
16. Masjuan J, Alvarez-Cermeno JC, Garcia-Barragan N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 2006; 66: 576-578.
17. Villar LM, Garcia-Barragan N, Sadaba MC, et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci 2008; 266: 34-37.
18. Gomez-Moreno M, Diaz-Sanchez M, Ramos-Gonzalez A. Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes. Mult Scler 2012; 18: 39-44.
19. Tumani H, Deisenhammer F, Giovannoni G, et al. Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol. 2011; 70: 520; author reply 521.
20. Korteweg T, Tintore M, Uitdehaag B, et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006; 5: 221-227.
21. Nielsen JM, Uitdehaag BM, Korteweg T, et al. Performance of the Swanton multiple sclerosis criteria for dissemination in space. Mult Scler 2010; 16: 985-987.
22. Montalban X, Kappos L, Freedman MS, et al. Application of the revised version of the 2010 McDonald diagnostic criteria: retrospective comparison using the BENEFIT clinical study dataset. Poster P648, ECTRIMS 2012.